From NASH to HCC: current concepts and future challenges
Caloric excess and sedentary lifestyle have led to a global epidemic of obesity and
metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity …
metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity …
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, representing the
sixth leading cause of cancer and the third leading cause of cancer-related mortality. Patient …
sixth leading cause of cancer and the third leading cause of cancer-related mortality. Patient …
[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Gut and liver, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …
[HTML][HTML] Development of a new nomogram including neutrophil-to-lymphocyte ratio to predict survival in patients with hepatocellular carcinoma undergoing …
YE Chon, H Park, HK Hyun, Y Ha, MN Kim, BK Kim… - Cancers, 2019 - mdpi.com
The neutrophil-to-lymphocyte ratio (NLR) has recently been reported to predict the
prognosis of hepatocellular carcinoma (HCC). We explored whether NLR predicted the …
prognosis of hepatocellular carcinoma (HCC). We explored whether NLR predicted the …
Nomogram and artificial neural network for prognostic performance on the albumin-bilirubin grade for hepatocellular carcinoma undergoing transarterial …
BY Zhong, CF Ni, JS Ji, GW Yin, L Chen, HD Zhu… - Journal of Vascular and …, 2019 - Elsevier
Purpose To construct the albumin-bilirubin (ALBI) grade and the Child-Turcotte-Pugh (CTP)
score based on nomograms, as well as to develop an artificial neural network (ANN) to …
score based on nomograms, as well as to develop an artificial neural network (ANN) to …
Intermediate stage hepatocellular carcinoma: a summary review
O Elshaarawy, A Gomaa, H Omar… - Journal of …, 2019 - Taylor & Francis
It is well known that intermediate stage hepatocellular carcinoma (HCC) encompasses the
widest class of patients with this disease. The main characteristic of this special sub-group of …
widest class of patients with this disease. The main characteristic of this special sub-group of …
Short-and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma
B Scheiner, G Ulbrich, M Mandorfer… - United European …, 2019 - journals.sagepub.com
Background Transarterial chemoembolization (TACE) affects hepatic perfusion, and might
have an impact on portal pressure in patients with hepatocellular carcinoma (HCC) …
have an impact on portal pressure in patients with hepatocellular carcinoma (HCC) …
Transarterial chemoembolization combined with radiofrequency ablation in the treatment of stage B1 intermediate hepatocellular carcinoma
F Liu, M Chen, J Mei, L Xu, R Guo, X Lin… - Journal of …, 2019 - Wiley Online Library
Background. Due to the heterogeneity of patients with Barcelona clinic liver cancer (BCLC)
intermediate‐stage hepatocellular carcinoma (HCC), Bolondi criteria were proposed and …
intermediate‐stage hepatocellular carcinoma (HCC), Bolondi criteria were proposed and …
[HTML][HTML] Intra arterial treatment of hepatocellular carcinoma: Comparison of MELD score variations between radio-embolization and chemo-embolization
J Delicque, M Hermida, L Piron, C Allimant… - Diagnostic and …, 2019 - Elsevier
Purpose The purpose of this study was to assess liver function deterioration, as assessed
using the model for end-stage liver disease (MELD) score variations, following transarterial …
using the model for end-stage liver disease (MELD) score variations, following transarterial …